Literature DB >> 1744588

A gene required for class II-restricted antigen presentation maps to the major histocompatibility complex.

E Mellins1, S Kempin, L Smith, T Monji, D Pious.   

Abstract

We have previously described a set of mutants (16.23-selected mutants) of a B lymphoblastoid cell line that are defective in the presentation of intact proteins to class II-restricted T cells, but effectively present immunogenic peptides. The mutations in these mutants are recessive in somatic cell hybrids and are not in Class II structural genes. Here, we report on a unique mutant, 5.2.4, in which a similar defect in class II-restricted antigen presentation has occurred in association with a one-megabase homozygous deletion in the class II region of the major histocompatibility complex (MHC). The defects in class II presentation among three of the 16.23-selected mutants, and between these mutants and 5.2.4, are noncomplementary in somatic cell hybrids. This suggests that the class II presentation-defective phenotype in all four mutants results from lesions in a single MHC-linked gene, a conclusion strengthened by the finding that in a hybrid made with a second, unrelated MHC deletion mutant, T2, the class II presentation defect in a 16.23-selected mutant is also not complemented. Mutant 5.2.4, in addition to its class II presentation defect, is also defective in surface expression of MHC class I molecules, most likely because its deletion encompasses the peptide supply factor 1 gene, whose function is known to be required for normal abundance of cell surface class I molecules. However, the surface abundance of class I molecules is normal in the 16.23-selected mutants, suggesting that the lesions affecting class I surface abundance and class II presentation result from mutations in different genes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1744588      PMCID: PMC2119029          DOI: 10.1084/jem.174.6.1607

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  35 in total

1.  Production of beta 2-microglobulin by normal and malignant human cell lines and peripheral lymphocytes.

Authors:  K Nilsson; P E Evrin; K I Welsh
Journal:  Transplant Rev       Date:  1974

2.  Structural relationship of the SB beta-chain gene to HLA-D-region genes and murine I-region genes.

Authors:  E O Long; J Gorski; B Mach
Journal:  Nature       Date:  1984 Jul 19-25       Impact factor: 49.962

3.  Genetic mapping of a human class II antigen beta-chain cDNA clone to the SB region of the HLA complex.

Authors:  M Roux-Dosseto; C Auffray; J W Lillie; J M Boss; D Cohen; R DeMars; C Mawas; J G Seidman; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

4.  H-2-linked low-molecular weight polypeptide antigens assemble into an unusual macromolecular complex.

Authors:  J J Monaco; H O McDevitt
Journal:  Nature       Date:  1984 Jun 28-Jul 4       Impact factor: 49.962

5.  Monoclonal antibody to a human histocompatibility alloantigen, HLA-A2.

Authors:  P Parham; W F Bodmer
Journal:  Nature       Date:  1978-11-23       Impact factor: 49.962

6.  Stable variants affecting B cell alloantigens in human lymphoid cells.

Authors:  D Pious
Journal:  Nature       Date:  1978-02-02       Impact factor: 49.962

7.  Report of the committee on the genetic constitution of chromosome 6. Oslo Conference (1981): Sixth International Workshop on Human Gene Mapping.

Authors:  L R Weitkamp; L U Lamm
Journal:  Cytogenet Cell Genet       Date:  1982

8.  Isolation and characterization of human B cell alloantigens.

Authors:  R J Billing; M Safani; P Peterson
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

9.  Recognition of HLA-B27 and related antigen by a monoclonal antibody.

Authors:  S A Ellis; C Taylor; A McMichael
Journal:  Hum Immunol       Date:  1982-08       Impact factor: 2.850

10.  Isolation of a cDNA clone for the human HLA-DR antigen alpha chain by using a synthetic oligonucleotide as a hybridization probe.

Authors:  D Stetler; H Das; J H Nunberg; R Saiki; R Sheng-Dong; K B Mullis; S M Weissman; H A Erlich
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

View more
  29 in total

Review 1.  HLA-DM and the MHC class II antigen presentation pathway.

Authors:  P E Jensen; D A Weber; W P Thayer; X Chen; C T Dao
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  DM influences the abundance of major histocompatibility complex class II alleles with low affinity for class II-associated invariant chain peptides via multiple mechanisms.

Authors:  Cornelia H Rinderknecht; Sujin Roh; Achal Pashine; Michael P Belmares; Namrata S Patil; Ning Lu; Phi Truong; Tieying Hou; Claudia Macaubas; Taejin Yoon; Nan Wang; Robert Busch; Elizabeth D Mellins
Journal:  Immunology       Date:  2010-04-12       Impact factor: 7.397

3.  Masking of a cathepsin G cleavage site in vivo contributes to the proteolytic resistance of major histocompatibility complex class II molecules.

Authors:  Timo Burster; Henriette Macmillan; Tieying Hou; James Schilling; Phi Truong; Bernhard O Boehm; Fang Zou; Kenneth Lau; Michael Strohman; Steven Schaffert; Robert Busch; Elizabeth D Mellins
Journal:  Immunology       Date:  2010-03-17       Impact factor: 7.397

4.  Mitotic recombination of yeast artificial chromosomes.

Authors:  J Ragoussis; J Trowsdale; D Markie
Journal:  Nucleic Acids Res       Date:  1992-06-25       Impact factor: 16.971

5.  An MHC class II restriction bias in CD4 T cell responses toward I-A is altered to I-E in DM-deficient mice.

Authors:  Paula R Menges; Scott A Jenks; Elizabeth K Bikoff; David R Friedmann; Zackery A G Knowlden; Andrea J Sant
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

6.  Allelic variants of the human putative peptide transporter involved in antigen processing.

Authors:  M Colonna; M Bresnahan; S Bahram; J L Strominger; T Spies
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

7.  Analysis of HLA-DMB mutants and -DMB genomic structure.

Authors:  J Shaman; E von Scheven; P Morris; M D Chang; E Mellins
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

Review 8.  Selection of the MHC class II-associated peptide repertoire by HLA-DM.

Authors:  S O Arndt; A B Vogt; G J Hämmerling; H Kropshofer
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

9.  Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium.

Authors:  V Groh; S Bahram; S Bauer; A Herman; M Beauchamp; T Spies
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

Review 10.  Selection of immunodominant epitopes during antigen processing is hierarchical.

Authors:  Scheherazade Sadegh-Nasseri; AeRyon Kim
Journal:  Mol Immunol       Date:  2018-08-24       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.